{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:17:42Z","timestamp":1792808262479,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","so-online.net","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.suronc.2016.05.014","type":"journal-article","created":{"date-parts":[[2016,5,22]],"date-time":"2016-05-22T18:26:52Z","timestamp":1463941612000},"page":"435-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacokinetics and the effect of heat on intraperitoneal pemetrexed using a murine model"],"prefix":"10.1016","volume":"25","author":[{"given":"David","family":"Badrudin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Perrault-Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bouchard-Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois A.","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2016.05.014_bib1","series-title":"Regional Cancer Therapy","first-page":"283","article-title":"Malignant peritoneal mesothelioma","author":"Mangiameli","year":"2007"},{"issue":"4","key":"10.1016\/j.suronc.2016.05.014_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jso.21055","article-title":"Consensus statement on peritoneal mesothelioma","volume":"98","author":"Deraco","year":"2008","journal-title":"J.\u00a0Surg. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2016.05.014_bib3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ejso.2006.03.012","article-title":"Comprehensive management of diffuse malignant peritoneal mesothelioma","volume":"32","author":"Sugarbaker","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2016.05.014_bib4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jso.21787","article-title":"Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research","volume":"103","author":"Baratti","year":"2011","journal-title":"J.\u00a0Surg. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2016.05.014_bib5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","article-title":"A\u00a0systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma","volume":"18","author":"Yan","year":"2007","journal-title":"Ann. Oncol."},{"issue":"36","key":"10.1016\/j.suronc.2016.05.014_bib6","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2016.05.014_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1634\/theoncologist.9-5-482","article-title":"FDA drug approval summaries: pemetrexed (Alimta)","volume":"9","author":"Hazarika","year":"2004","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.suronc.2016.05.014_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","article-title":"Malignant peritoneal mesothelioma-results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent","volume":"64","author":"Carteni","year":"2009","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.suronc.2016.05.014_bib9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/ejso.2000.0983","article-title":"Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model","volume":"26","author":"Pestieau","year":"2000","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2016.05.014_bib10","doi-asserted-by":"crossref","first-page":"890450","DOI":"10.1155\/2012\/890450","article-title":"Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"issue":"1","key":"10.1016\/j.suronc.2016.05.014_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SLA.0b013e3182193143","article-title":"Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model","volume":"254","author":"Piche","year":"2011","journal-title":"Ann. Surg."},{"issue":"21","key":"10.1016\/j.suronc.2016.05.014_bib12","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","article-title":"Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial","volume":"26","author":"Simon","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2016.05.014_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/030089161109700105","article-title":"Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience","volume":"97","author":"Lainakis","year":"2011","journal-title":"Tumori"},{"issue":"9","key":"10.1016\/j.suronc.2016.05.014_bib14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ejso.2008.09.010","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma","volume":"35","author":"Yano","year":"2009","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2016.05.014_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jso.21177","article-title":"Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience","volume":"99","author":"Chua","year":"2009","journal-title":"J.\u00a0Surg. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2016.05.014_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/bjs.7263","article-title":"Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma","volume":"98","author":"Chua","year":"2011","journal-title":"Br. J. Surg."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416300330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416300330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T11:58:02Z","timestamp":1567943882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740416300330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0960740416300330"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2016.05.014","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and the effect of heat on intraperitoneal pemetrexed using a murine model","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2016.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}